237 related articles for article (PubMed ID: 28607030)
1. miRNA-340 inhibits osteoclast differentiation via repression of MITF.
Zhao H; Zhang J; Shao H; Liu J; Jin M; Chen J; Huang Y
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607030
[TBL] [Abstract][Full Text] [Related]
2. NF-κB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression.
Zhang Y; Ma C; Liu C; Wu W
Life Sci; 2020 Oct; 258():118093. PubMed ID: 32673666
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.
Yu FY; Xie CQ; Sun JT; Peng W; Huang XW
Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879
[TBL] [Abstract][Full Text] [Related]
4. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
5. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
6. The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF).
Bronisz A; Carey HA; Godlewski J; Sif S; Ostrowski MC; Sharma SM
J Biol Chem; 2014 Jan; 289(1):326-34. PubMed ID: 24257758
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
8. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
[TBL] [Abstract][Full Text] [Related]
9. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.
Hu R; Sharma SM; Bronisz A; Srinivasan R; Sankar U; Ostrowski MC
Mol Cell Biol; 2007 Jun; 27(11):4018-27. PubMed ID: 17403896
[TBL] [Abstract][Full Text] [Related]
10. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.
Sharma SM; Sif S; Ostrowski MC; Sankar U
J Cell Physiol; 2009 Jul; 220(1):230-7. PubMed ID: 19288495
[TBL] [Abstract][Full Text] [Related]
11. Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF.
Zhang J; Zhao H; Chen J; Xia B; Jin Y; Wei W; Shen J; Huang Y
FEBS Lett; 2012 Sep; 586(19):3255-62. PubMed ID: 22771905
[TBL] [Abstract][Full Text] [Related]
12. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
13. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
14. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
16. TGF-β Negatively Regulates Mitf-E Expression and Canine Osteoclastogenesis.
Asai K; Hisasue M; Shimokawa F; Funaba M; Murakami M
Biochem Genet; 2018 Oct; 56(5):542-552. PubMed ID: 29680988
[TBL] [Abstract][Full Text] [Related]
17. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB.
Ripoll VM; Meadows NA; Raggatt LJ; Chang MK; Pettit AR; Cassady AI; Hume DA
Gene; 2008 Apr; 413(1-2):32-41. PubMed ID: 18313864
[TBL] [Abstract][Full Text] [Related]
18. MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B.
Sun L; Lian JX; Meng S
Cell Mol Biol Lett; 2019; 24():23. PubMed ID: 30976285
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of osteoclast differentiation induced by IL-1.
Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
[TBL] [Abstract][Full Text] [Related]
20. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.
Feng H; Cheng T; Steer JH; Joyce DA; Pavlos NJ; Leong C; Kular J; Liu J; Feng X; Zheng MH; Xu J
J Biol Chem; 2009 May; 284(21):14667-76. PubMed ID: 19321441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
